sthrn labs is launching soon. Browse the catalog, review our COAs, and inquire to order.
Semax
Semax is a synthetic heptapeptide analogue of ACTH studied for its potential neuroprotective and cognitive-enhancing properties in preclinical research models. For research use only.
Compound information
What is Semax?
Stability information
Research highlights
BDNF/NGF upregulation
Research on this ACTH(4–10) analog and neurotrophic factor expression.
Neuroprotection in ischemia
Studies examining protective effects in ischemic and stroke models.
Monoaminergic modulation
Investigating dopaminergic and serotonergic system effects.
Non-hormonal ACTH analog
Mechanistic work on cognitive activity without steroidogenic ACTH effects.
Sources & references
Semax, an analog of ACTH(4–10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus
Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats
The efficacy of Semax in the treatment of patients at different stages of ischemic stroke
All citations link directly to primary literature. sthrn labs does not reproduce, excerpt, or summarize article content.
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
